Publicaciones en colaboración con investigadores/as de Universidade Federal do Paraná (2)

2020

  1. Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6)

    Diabetes, Obesity and Metabolism, Vol. 22, Núm. 8, pp. 1339-1347

2019

  1. Effect of liraglutide on cardiovascular outcomes in elderly patients: A post hoc analysis of a randomized controlled trial

    Annals of Internal Medicine